{"id":243202,"date":"2026-09-11T10:40:51","date_gmt":"2026-09-11T05:10:51","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=243202"},"modified":"2026-09-11T10:40:51","modified_gmt":"2026-09-11T05:10:51","slug":"integrated-healthcare-stock-rises-100-percent-in-5-years","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/","title":{"rendered":"This Integrated Healthcare Stock Rises 100% in 5 Years: Can the Demerger Push It Higher?"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>CMP approx Rs 8,900 (10 Sep 2026). 5-year return 100.19%. 52W range Rs 6,697 to Rs 9,050. Market cap approx Rs 1,28,831 Cr. Q1 FY27 PAT Rs 610 Cr, up 38%.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Apollo Hospitals is the integrated healthcare stock behind a 5-year return of approximately 100%. The share rose from around Rs 4,450 in September 2021 to about Rs 8,900 on 10 September 2026 as hospital earnings grew, pharmacy scale expanded and digital losses narrowed. The 1-year return is also positive at 21.08%.<\/p>\n<\/div>\n<p>This integrated healthcare stock has doubled investor money over five years. A Chennai-based group that runs hospitals, a nationwide pharmacy network and a digital health app delivered a 5-year return of 100.19% as of 10 September 2026, ranking 53rd in a screen of 101 large-cap and mid-cap NSE shares.<\/p>\n<p>The company is <strong><a href='https:\/\/univest.in\/stocks\/apollohosp\/apollo-hospitals-enterprise-ltd-share-price-today'>Apollo Hospitals Enterprise Ltd<\/a> (NSE: APOLLOHOSP)<\/strong>, India&#8217;s largest private healthcare group by revenue. The Apollo Hospitals share price closed at approximately Rs 8,900 on 10 September 2026, up from around Rs 4,450 five years earlier, and the company is valued at approximately Rs 1,28,831 crore. Unlike many peers, this integrated healthcare stock has also kept rising over the last 12 months.<\/p>\n<p style=\"margin-top:24px;\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#How_Much_Has_This_Integrated_Healthcare_Stock_Gained_in_5_Years\" title=\"How Much Has This Integrated Healthcare Stock Gained in 5 Years?\">How Much Has This Integrated Healthcare Stock Gained in 5 Years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Why_Did_This_Integrated_Healthcare_Stock_Rise_100_in_5_Years\" title=\"Why Did This Integrated Healthcare Stock Rise 100% in 5 Years?\">Why Did This Integrated Healthcare Stock Rise 100% in 5 Years?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#1_Early_Phase_Pandemic_Demand_and_a_Sharp_Reset\" title=\"1. Early Phase: Pandemic Demand and a Sharp Reset\">1. Early Phase: Pandemic Demand and a Sharp Reset<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#2_Hospitals_Became_More_Productive\" title=\"2. Hospitals Became More Productive\">2. Hospitals Became More Productive<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#3_Pharmacy_and_Apollo_247_Moved_Towards_Profit\" title=\"3. Pharmacy and Apollo 24\/7 Moved Towards Profit\">3. Pharmacy and Apollo 24\/7 Moved Towards Profit<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#4_The_HealthCo_Demerger_Unlocks_Value\" title=\"4. The HealthCo Demerger Unlocks Value\">4. The HealthCo Demerger Unlocks Value<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#5_Capacity_Pipeline_of_5800_Beds\" title=\"5. Capacity Pipeline of 5,800 Beds\">5. Capacity Pipeline of 5,800 Beds<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#What_Makes_This_Integrated_Healthcare_Stock_Different\" title=\"What Makes This Integrated Healthcare Stock Different?\">What Makes This Integrated Healthcare Stock Different?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Integrated_Healthcare_Stock_Financials_Profit_Up_38_in_Q1_FY27\" title=\"Integrated Healthcare Stock Financials: Profit Up 38% in Q1 FY27\">Integrated Healthcare Stock Financials: Profit Up 38% in Q1 FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Valuation_of_This_Integrated_Healthcare_Stock\" title=\"Valuation of This Integrated Healthcare Stock\">Valuation of This Integrated Healthcare Stock<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Who_Owns_This_Integrated_Healthcare_Stock\" title=\"Who Owns This Integrated Healthcare Stock?\">Who Owns This Integrated Healthcare Stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Risks_for_This_Integrated_Healthcare_Stock\" title=\"Risks for This Integrated Healthcare Stock\">Risks for This Integrated Healthcare Stock<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#1_Rich_Valuation\" title=\"1. Rich Valuation\">1. Rich Valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#2_Demerger_Execution\" title=\"2. Demerger Execution\">2. Demerger Execution<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#3_New_Hospital_Drag_and_Rising_Debt\" title=\"3. New Hospital Drag and Rising Debt\">3. New Hospital Drag and Rising Debt<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#4_Pricing_Regulation_and_Competition\" title=\"4. Pricing Regulation and Competition\">4. Pricing Regulation and Competition<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Apollo_Hospitals_Share_Analyst_View\" title=\"Apollo Hospitals Share: Analyst View\">Apollo Hospitals Share: Analyst View<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Apollo_Hospitals_Share_Price_Target\" title=\"Apollo Hospitals Share Price Target\">Apollo Hospitals Share Price Target<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Which_integrated_healthcare_stock_rose_100_in_5_years\" title=\"Which integrated healthcare stock rose 100% in 5 years?\">Which integrated healthcare stock rose 100% in 5 years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#What_is_the_Apollo_Hospitals_share_price_today\" title=\"What is the Apollo Hospitals share price today?\">What is the Apollo Hospitals share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Why_did_the_Apollo_Hospitals_share_rise_over_5_years\" title=\"Why did the Apollo Hospitals share rise over 5 years?\">Why did the Apollo Hospitals share rise over 5 years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#What_is_the_Apollo_Hospitals_share_price_target\" title=\"What is the Apollo Hospitals share price target?\">What is the Apollo Hospitals share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#How_did_Apollo_Hospitals_perform_in_Q1_FY27\" title=\"How did Apollo Hospitals perform in Q1 FY27?\">How did Apollo Hospitals perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#When_will_Apollo_HealthCo_be_listed\" title=\"When will Apollo HealthCo be listed?\">When will Apollo HealthCo be listed?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Is_Apollo_Hospitals_share_overvalued\" title=\"Is Apollo Hospitals share overvalued?\">Is Apollo Hospitals share overvalued?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/integrated-healthcare-stock-rises-100-percent-in-5-years\/#Did_Apollo_Hospitals_issue_a_bonus_or_split_shares_in_the_last_5_years\" title=\"Did Apollo Hospitals issue a bonus or split shares in the last 5 years?\">Did Apollo Hospitals issue a bonus or split shares in the last 5 years?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"How_Much_Has_This_Integrated_Healthcare_Stock_Gained_in_5_Years\"><\/span><strong>How Much Has This Integrated Healthcare Stock Gained in 5 Years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This integrated healthcare stock has gained approximately 100% in five years, which means Rs 1 lakh invested in September 2021 would be worth roughly Rs 2 lakh today. That works out to a compound annual return of around 14.9%.<\/p>\n<p>The shorter periods are steady rather than spectacular. The 1-year return is 21.08% (rank 60) and the 3-year return is 74.58% (rank 58). Here is how this integrated healthcare stock has performed across time frames in our screen:<\/p>\n<table>\n<thead>\n<tr>\n<th>Period<\/th>\n<th>Return (%)<\/th>\n<th>Rank (out of 101)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1 Month<\/td>\n<td>2.53%<\/td>\n<td>61<\/td>\n<\/tr>\n<tr>\n<td>6 Months<\/td>\n<td>18.84%<\/td>\n<td>66<\/td>\n<\/tr>\n<tr>\n<td>1 Year<\/td>\n<td>21.08%<\/td>\n<td>60<\/td>\n<\/tr>\n<tr>\n<td>3 Years<\/td>\n<td>74.58%<\/td>\n<td>58<\/td>\n<\/tr>\n<tr>\n<td>5 Years<\/td>\n<td>100.19%<\/td>\n<td>53<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Returns are simple price changes and are not annualised. There was no stock split or bonus issue in the five-year window, and the face value has stayed at Rs 5 per share, so the 100% figure is real price appreciation.<\/p>\n<p>The 52-week range runs from around Rs 6,697 to Rs 9,050. At approximately Rs 8,900, the Apollo Hospitals share price sits within about 2% of its 52-week high and roughly 33% above its 52-week low.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Did_This_Integrated_Healthcare_Stock_Rise_100_in_5_Years\"><\/span><strong>Why Did This Integrated Healthcare Stock Rise 100% in 5 Years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This integrated healthcare stock doubled because revenue grew about 72% between FY22 and FY26, profit rose about 82%, the hospital business kept lifting revenue per patient, and investors began to value the pharmacy and digital arm as a separate growth engine. The gains came in two phases, with a sharp dip in between.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"1_Early_Phase_Pandemic_Demand_and_a_Sharp_Reset\"><\/span><strong>1. Early Phase: Pandemic Demand and a Sharp Reset<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In FY22, the company earned a net profit of about Rs 1,101 crore on revenue of approximately Rs 14,741 crore, helped by pandemic-era demand and vaccination services. This integrated healthcare stock touched fresh highs in late 2021.<\/p>\n<p>That tailwind faded quickly. FY23 profit fell to around Rs 888 crore as Covid-related income disappeared and the digital platform burned cash. This integrated healthcare stock spent much of 2022 and early 2023 moving sideways, which explains why the five-year return is lower than the recent run suggests.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Hospitals_Became_More_Productive\"><\/span><strong>2. Hospitals Became More Productive<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The core hospital business is the main reason this integrated healthcare stock recovered. In Q1 FY27, healthcare services revenue rose 22% to approximately Rs 3,567 crore, with a segment EBITDA margin of about 24%. Overall occupancy improved to 70% from 65% a year earlier, and average revenue per inpatient rose 8% to around Rs 1,86,630.<\/p>\n<p>The group now runs approximately 9,857 census beds across 77 hospitals. Management has guided for hospital revenue growth of 18% to 20% in FY27, and established hospitals are expected to grow 13% to 14% a year over the next two years. That visibility is a key support for this integrated healthcare stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Pharmacy_and_Apollo_247_Moved_Towards_Profit\"><\/span><strong>3. Pharmacy and Apollo 24\/7 Moved Towards Profit<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The pharmacy and digital arm, Apollo HealthCo, posted Q1 FY27 revenue of approximately Rs 2,977 crore, up 20%. It runs more than 7,440 offline pharmacy stores and added 151 in the quarter.<\/p>\n<p>Apollo 24\/7 was once the biggest worry for this integrated healthcare stock. The digital platform&#8217;s losses narrowed to approximately Rs 9.7 crore in Q1 FY27 from about Rs 48.7 crore a year earlier. It has around 49 million registered users, and management expects full breakeven by Q3 FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_The_HealthCo_Demerger_Unlocks_Value\"><\/span><strong>4. The HealthCo Demerger Unlocks Value<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The biggest recent re-rating trigger for this integrated healthcare stock is the plan to demerge and separately list the pharmacy distribution and digital business. The tribunal approved the scheme on 5 May 2026, and listing is targeted for the January to March 2027 quarter.<\/p>\n<p>Management is targeting annualised HealthCo revenue of about Rs 25,000 crore by Q4 FY27, with an exit EBITDA margin of 6.5% to 7%. Investors who believe the separate listing will reveal hidden value have supported this integrated healthcare stock through 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Capacity_Pipeline_of_5800_Beds\"><\/span><strong>5. Capacity Pipeline of 5,800 Beds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The company plans to add more than 5,800 beds over the next five years, taking capacity to around 14,100 beds by FY31. In Q1 FY27 it opened a 180-bed hospital in Sarjapur, Bengaluru, and added 148 beds through expansions in Indore and Guwahati. A steady pipeline gives this integrated healthcare stock visible growth for several years.<\/p>\n<p style=\"margin-top:24px;\"><strong>Check the Univest Screener for Live Fundamentals of High-Return Stocks<\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Makes_This_Integrated_Healthcare_Stock_Different\"><\/span><strong>What Makes This Integrated Healthcare Stock Different?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This integrated healthcare stock is different because it earns money at almost every step of a patient&#8217;s journey, not just inside a hospital. The group reports three main segments, and each has its own growth driver.<\/p>\n<p>Healthcare services, which covers the hospitals, contributed about half of Q1 FY27 revenue and most of the profit. Apollo HealthCo, which covers the pharmacy stores, distribution and the Apollo 24\/7 app, brought in roughly 42% of revenue. Apollo Health and Lifestyle, which runs clinics, diagnostics and day-care centres, added approximately Rs 499 crore, up 15%.<\/p>\n<p>This mix gives this integrated healthcare stock more than one engine. When hospital growth slows, pharmacy volumes can keep revenue moving, and the app feeds patients into both. The trade-off is that pharmacy margins are thin, so investors in this integrated healthcare stock watch the blended margin closely.<\/p>\n<p>The group has also trimmed non-core assets to focus capital. It agreed to sell its fertility and maternity business for approximately Rs 1,550 crore, freeing funds for new hospitals and the digital platform. Such moves have helped this integrated healthcare stock keep debt in check while expanding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Integrated_Healthcare_Stock_Financials_Profit_Up_38_in_Q1_FY27\"><\/span><strong>Integrated Healthcare Stock Financials: Profit Up 38% in Q1 FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The latest numbers show this integrated healthcare stock is growing profit faster than revenue. Q1 FY27 revenue grew about 21% year on year, while net profit rose around 38% to Rs 610 crore as margins widened.<\/p>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Revenue (Rs Cr)<\/th>\n<th>EBITDA (Rs Cr)<\/th>\n<th>Net Profit (Rs Cr)<\/th>\n<th>Net Margin (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Jun 2025<\/td>\n<td>5,882<\/td>\n<td>892<\/td>\n<td>441<\/td>\n<td>7.41<\/td>\n<\/tr>\n<tr>\n<td>Sep 2025<\/td>\n<td>6,358<\/td>\n<td>996<\/td>\n<td>494<\/td>\n<td>7.57<\/td>\n<\/tr>\n<tr>\n<td>Dec 2025<\/td>\n<td>6,530<\/td>\n<td>1,018<\/td>\n<td>516<\/td>\n<td>7.98<\/td>\n<\/tr>\n<tr>\n<td>Mar 2026<\/td>\n<td>6,649<\/td>\n<td>1,055<\/td>\n<td>551<\/td>\n<td>8.01<\/td>\n<\/tr>\n<tr>\n<td>Jun 2026<\/td>\n<td>7,092<\/td>\n<td>1,141<\/td>\n<td>610<\/td>\n<td>8.24<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Revenue figures include other income. For this integrated healthcare stock, profit has risen for four straight quarters, and net margin has improved from 7.41% to 8.24% over the last five quarters.<\/p>\n<p>On a full-year basis, FY26 revenue was approximately Rs 25,420 crore, up about 16%, and net profit grew around 33% to Rs 2,003 crore. Diluted EPS climbed from Rs 62.50 in FY24 to Rs 134.94 in FY26. Operating cash flow reached approximately Rs 2,856 crore in FY26, which funded capital spending of about Rs 1,962 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_of_This_Integrated_Healthcare_Stock\"><\/span><strong>Valuation of This Integrated Healthcare Stock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock trades at a trailing PE of approximately 58.8 times, below the industry PE of around 68.5. The price-to-book ratio is about 13.5, and return on equity is approximately 20.5%. Debt to equity stood at about 0.69 at the end of FY26, and the dividend yield is a modest 0.23%. In short, this integrated healthcare stock is expensive in absolute terms but not out of line with its sector.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Who_Owns_This_Integrated_Healthcare_Stock\"><\/span><strong>Who Owns This Integrated Healthcare Stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Foreign institutions are the largest owners of this integrated healthcare stock, holding 41.5% in June 2026. Domestic institutions have been steadily buying while foreign investors have trimmed their stake.<\/p>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Promoters (%)<\/th>\n<th>FII (%)<\/th>\n<th>DII (%)<\/th>\n<th>Public (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Jun 2025<\/td>\n<td>29.34<\/td>\n<td>43.49<\/td>\n<td>21.34<\/td>\n<td>5.83<\/td>\n<\/tr>\n<tr>\n<td>Sep 2025<\/td>\n<td>28.02<\/td>\n<td>44.20<\/td>\n<td>21.12<\/td>\n<td>6.66<\/td>\n<\/tr>\n<tr>\n<td>Dec 2025<\/td>\n<td>28.02<\/td>\n<td>43.54<\/td>\n<td>21.51<\/td>\n<td>6.94<\/td>\n<\/tr>\n<tr>\n<td>Mar 2026<\/td>\n<td>28.02<\/td>\n<td>42.62<\/td>\n<td>22.76<\/td>\n<td>6.60<\/td>\n<\/tr>\n<tr>\n<td>Jun 2026<\/td>\n<td>28.02<\/td>\n<td>41.50<\/td>\n<td>23.72<\/td>\n<td>6.77<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Promoter holding dipped from 29.34% to 28.02% in the September 2025 quarter and has been stable since. DII holding rose from 21.34% to 23.72% over the year, which suggests local funds have been absorbing foreign selling in this integrated healthcare stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_for_This_Integrated_Healthcare_Stock\"><\/span><strong>Risks for This Integrated Healthcare Stock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This integrated healthcare stock carries real risks despite its strong run. Investors should weigh these before deciding on an entry point.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"1_Rich_Valuation\"><\/span><strong>1. Rich Valuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At around 59 times earnings and over 13 times book value, a lot of future growth is already priced in. Any slowdown in hospital growth or a delay in the demerger could hit this integrated healthcare stock hard.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Demerger_Execution\"><\/span><strong>2. Demerger Execution<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The HealthCo listing depends on regulatory approvals and market conditions. If the listing is delayed beyond March 2027 or values the business below expectations, some of the recent premium in this integrated healthcare stock could fade.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_New_Hospital_Drag_and_Rising_Debt\"><\/span><strong>3. New Hospital Drag and Rising Debt<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>New hospitals usually lose money in their first two to three years. With more than 5,800 beds in the pipeline and capital spending near Rs 2,000 crore a year, borrowings may rise and early losses could weigh on margins.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Pricing_Regulation_and_Competition\"><\/span><strong>4. Pricing Regulation and Competition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Government moves to cap procedure or drug prices, or changes to insurance rates, could squeeze margins. Competition from other large chains and online pharmacies adds further pressure on this integrated healthcare stock. The pharmacy arm in particular faces aggressive discounting from quick-commerce and e-pharmacy players.<\/p>\n<p style=\"margin-top:24px;\"><strong>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track the Apollo Hospitals share price live<\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Apollo_Hospitals_Share_Analyst_View\"><\/span><strong>Apollo Hospitals Share: Analyst View<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Analysts remain broadly positive on the Apollo Hospitals share after the Q1 FY27 results. They highlight margin expansion, falling digital losses and the demerger as the three main drivers for this integrated healthcare stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Apollo_Hospitals_Share_Price_Target\"><\/span><strong>Apollo Hospitals Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>After the Q1 FY27 results in August 2026, a domestic brokerage set an Apollo Hospitals share price target of Rs 10,446 with a buy rating, implying about 17% upside from around Rs 8,900. In May 2026, two other domestic brokerages set targets of Rs 9,660 and Rs 9,350.<\/p>\n<p>The highest Apollo Hospitals share price target mentioned above sits well above the 52-week high of Rs 9,050. A decisive move past that level would put the Apollo Hospitals share price in new territory, while the 52-week low near Rs 6,697 marks the main support. Any Apollo Hospitals share price target is an estimate and not a promise of returns.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This integrated healthcare stock has doubled in five years on the back of more productive hospitals, a larger pharmacy network and a digital arm that is nearing breakeven. The 21% gain over the last year shows that momentum has held up better than at many peers.<\/p>\n<p>The Apollo Hospitals share price now reflects high expectations, with a PE near 59 and the HealthCo listing still ahead. For long-term investors, this integrated healthcare stock offers a diversified healthcare story, but position sizing and patience matter at current valuations.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information and may or may not be accurate. Please verify all data independently before making any investment decision. Past returns do not guarantee future returns. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_integrated_healthcare_stock_rose_100_in_5_years\"><\/span><strong>Which integrated healthcare stock rose 100% in 5 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Apollo Hospitals Enterprise Ltd (NSE: APOLLOHOSP) delivered a 5-year return of approximately 100.19% as of 10 September 2026. The share rose from around Rs 4,450 to approximately Rs 8,900 over that period.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Apollo_Hospitals_share_price_today\"><\/span><strong>What is the Apollo Hospitals share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Apollo Hospitals share price closed at approximately Rs 8,900 on 10 September 2026. Its 52-week range is around Rs 6,697 to Rs 9,050.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_the_Apollo_Hospitals_share_rise_over_5_years\"><\/span><strong>Why did the Apollo Hospitals share rise over 5 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The rise came from strong growth in the hospital business, a larger pharmacy network, narrowing losses at Apollo 24\/7 and the planned demerger of Apollo HealthCo. Net profit grew from about Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Apollo_Hospitals_share_price_target\"><\/span><strong>What is the Apollo Hospitals share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> After the Q1 FY27 results, a domestic brokerage set a target of Rs 10,446 with a buy rating. Other domestic brokerages set targets of Rs 9,660 and Rs 9,350 in May 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Apollo_Hospitals_perform_in_Q1_FY27\"><\/span><strong>How did Apollo Hospitals perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue grew about 21% year on year to over Rs 7,000 crore, and net profit rose around 38% to Rs 610 crore. Hospital occupancy improved to 70% from 65%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_will_Apollo_HealthCo_be_listed\"><\/span><strong>When will Apollo HealthCo be listed?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company has targeted the listing of the demerged pharmacy and digital business in the January to March 2027 quarter. The tribunal approved the scheme on 5 May 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Apollo_Hospitals_share_overvalued\"><\/span><strong>Is Apollo Hospitals share overvalued?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock trades at a PE of around 58.8 times, which is below the industry PE of about 68.5 but high in absolute terms. Investors should consider growth visibility and demerger timing before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Apollo_Hospitals_issue_a_bonus_or_split_shares_in_the_last_5_years\"><\/span><strong>Did Apollo Hospitals issue a bonus or split shares in the last 5 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. There was no stock split or bonus issue in the five-year window, and the face value remains Rs 5 per share. The 100% return reflects genuine price appreciation.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which integrated healthcare stock rose 100% in 5 years?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Apollo Hospitals Enterprise Ltd (NSE: APOLLOHOSP) delivered a 5-year return of approximately 100.19% as of 10 September 2026. The share rose from around Rs 4,450 to approximately Rs 8,900 over that period.\"}},{\"@type\":\"Question\",\"name\":\"What is the Apollo Hospitals share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Apollo Hospitals share price closed at approximately Rs 8,900 on 10 September 2026. Its 52-week range is around Rs 6,697 to Rs 9,050.\"}},{\"@type\":\"Question\",\"name\":\"Why did the Apollo Hospitals share rise over 5 years?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The rise came from strong growth in the hospital business, a larger pharmacy network, narrowing losses at Apollo 24\/7 and the planned demerger of Apollo HealthCo. Net profit grew from about Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26.\"}},{\"@type\":\"Question\",\"name\":\"What is the Apollo Hospitals share price target?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"After the Q1 FY27 results, a domestic brokerage set a target of Rs 10,446 with a buy rating. Other domestic brokerages set targets of Rs 9,660 and Rs 9,350 in May 2026.\"}},{\"@type\":\"Question\",\"name\":\"How did Apollo Hospitals perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue grew about 21% year on year to over Rs 7,000 crore, and net profit rose around 38% to Rs 610 crore. Hospital occupancy improved to 70% from 65%.\"}},{\"@type\":\"Question\",\"name\":\"When will Apollo HealthCo be listed?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The company has targeted the listing of the demerged pharmacy and digital business in the January to March 2027 quarter. The tribunal approved the scheme on 5 May 2026.\"}},{\"@type\":\"Question\",\"name\":\"Is Apollo Hospitals share overvalued?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock trades at a PE of around 58.8 times, which is below the industry PE of about 68.5 but high in absolute terms. Investors should consider growth visibility and demerger timing before deciding.\"}},{\"@type\":\"Question\",\"name\":\"Did Apollo Hospitals issue a bonus or split shares in the last 5 years?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. There was no stock split or bonus issue in the five-year window, and the face value remains Rs 5 per share. The 100% return reflects genuine price appreciation.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>One hospital, pharmacy and digital health group has turned Rs 1 lakh into roughly Rs 2 lakh in five years. Here is what powered the 100% rise and the risks ahead.<\/p>\n","protected":false},"author":29,"featured_media":243200,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[],"class_list":["post-243202","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["243200"],"rank_math_title":["Integrated Healthcare Stock Up 100% in 5 Years: Key Drivers"],"rank_math_description":["This integrated healthcare stock rose approximately 100% in 5 years, from around Rs 4,450 to Rs 8,900. See Q1 FY27 results, the demerger plan, targets and key risks."],"rank_math_focus_keyword":["integrated healthcare stock"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/integrated-healthcare-stock-rises-100-percent-in-5-years.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/243202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=243202"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/243202\/revisions"}],"predecessor-version":[{"id":243203,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/243202\/revisions\/243203"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/243200"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=243202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=243202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=243202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}